Common Prognostic Scoring Systems for Patients Presenting with Brain Metastases
| Autor: | Erkan Topkan, Ahmet Kucuk, Berrin Pehlivan, Duygu Sezen, Esma Didem Ikiz, Eyub Yasar Aydemir, Nulifer Kılıc Durankus, Sukran Senyurek, Ugur Selek, Yasemin Bolukbasi |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Chemotherapy business.industry medicine.medical_treatment Cancer Treatment options Disease medicine.disease Disease course Palliative radiotherapy General wellbeing medicine General Earth and Planetary Sciences business Intensive care medicine General Environmental Science Brain metastasis |
| Zdroj: | Clinical Oncology and Research. :1-8 |
| ISSN: | 2613-4942 |
| DOI: | 10.31487/j.cor.2020.03.03 |
| Popis: | Brain metastases (BM) of various primaries merely remain the most prevalent type of intracranial tumors, and approximately 25% of all cancer patients are diagnosed with this poor prognostic disease condition somewhere during their treatment course. Contingent upon the general wellbeing status of the potential patient, currently available major treatment options typically include palliative radiotherapy, chemotherapy, and best supportive care. Various published studies have convincingly shown the likelihood to stratify BM patients into particular prognostic gatherings according to the conceivable combinations of multiple patients- and tumor-related characteristics; namely the prognostic scoring systems, which might be useful in the accurate prediction of survival, and thusly, the appropriate choice of the best-fit treatment alternative. In this present article, we meant to review the pros and cons of the as of now accessible and broadly acknowledged prognostic scoring systems for BMs and their clinical values. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|